0001209191-23-041343.txt : 20230705
0001209191-23-041343.hdr.sgml : 20230705
20230705194704
ACCESSION NUMBER: 0001209191-23-041343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230701
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bender Jeremy
CENTRAL INDEX KEY: 0001863107
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 231071599
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BLVD.
STREET 2: SUITE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Day One Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001845337
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832415215
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650 484-0899
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC
DATE OF NAME CHANGE: 20210209
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-01
0
0001845337
Day One Biopharmaceuticals, Inc.
DAWN
0001863107
Bender Jeremy
2000 SIERRA POINT PARKWAY, SUITE 501
BRISBANE
CA
94005
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-07-01
4
J
0
240288
0.00
D
939196
D
Common Stock
2023-07-01
4
J
0
240288
0.00
A
240288
I
By Melissa Claire Bender
Common Stock
2023-07-01
4
G
0
240288
0.00
D
698908
D
Common Stock
2023-07-01
4
G
0
240288
0.00
A
240288
I
See Footnote
Common Stock
2023-07-01
4
G
0
240288
0.00
D
0
I
By Melissa Claire Bender
Common Stock
2023-07-01
4
G
0
240288
0.00
A
240288
I
See Footnote
Common Stock
2023-07-01
4
G
0
59737
0.00
D
221837
I
See Footnote
Common Stock
2023-07-01
4
G
0
59737
0.00
A
300025
I
See Footnote
Common Stock
2023-07-01
4
G
0
29938
0.00
D
251636
I
See Footnote
Common Stock
2023-07-01
4
G
0
29938
0.00
A
270226
I
See Footnote
These shares were transferred as a division of marital property to the Reporting Person's spouse, Melissa Claire Bender.
Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration.
Represents shares held by The Jeremy Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023.
Represents shares of the Reporting Person's spouse that were transferred as a bona fide gift for no consideration.
Represents shares held by The Melissa Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023.
Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust that were transferred as a bona fide gift for no consideration.
Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement, dated March 29, 2022 of which the Reporting Person is trustee.
Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust that were transferred as a bona fide gift for no consideration.
Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement, dated March 29, 2022 of which the Reporting Person's spouse is trustee.
/s/ Charles N. York II, Attorney-in-Fact
2023-07-05